CAS: 767-05-5; 3-Cyclopentylpropan-1-Ol

相似化合物

140-77-2 766-00-7 4300-02-1

上下游产品

CAS号140-77-2 3-环戊基丙酸 | CAS号109-63-7 三氟化硼乙醚 | CAS号503-30-0 三甲氧基酯 | CAS号33240-34-5 环戊基溴化镁 | CAS号104-97-2 3-环戊基丙酰氯 | CAS号287-92-3 环戊烷 | CAS号107-18-6 烯丙醇 | CAS号60-29-7 乙醚 | CAS号71-43-2 苯 | CAS号106211-63-6 3-iodopropylcyc... | CAS号821-55-6 2-壬酮 | CAS号6821-87-0 Cyclopentanepro... | CAS号6053-89-0 环戊烷丙醛

📜3-环戊基丙酸置于苯硅烷,C32H25Mnn4O3P(1+)*br(1-),水体系中,用 四氢呋喃 作为反应溶剂,化学反应 2.0H,以95%的收率获得产物3-环戊基-1-丙醇
参考文献:带有三唑配体的mn(i)配合物催化羰基和羧基的氢化硅烷化
标题:带有三唑配体的mn(i)配合物催化羰基和羧基的氢化硅烷化
摘要:据报道,带有三唑配体的锰(i)配合物是羰基和羧基化合物氢化硅烷化的催化剂.所需的反应在催化剂负载低至0.25至1 Mol%的情况下,可在80oc下于3小时内轻松进行.因此,对于包括酮,酯和羧酸在内的多种底物,可以获得非常好至优异的醇收率,说明了金属/配体组合的多功能性.
DOI:10.1039/c9Cy01738K

专利信息

专利号:US-3978140-A
优先权日:1974-09-23
标题 :Process for the preparation of carbinols
发明人：LANE CLINTON FISHER; MYATT HAL LESLIE
权利人:ALDRICH BORANES INC
摘要:Organic compounds containing a carboxylic acid or carboxylic acid anhydride group are reduced when contacted with an alkali metal borohydride and a boron trihalide in a liquid medium in which diborane is soluble in the form of a labile borane adduct. Hydrolysis of the reaction mixture then provides a useful synthesis of the corresponding carbinols. n The alkali metal borohydride-boron trihalide reagent may either be preformed and reacted subsequently with an organic compound containing a carboxylic acid or anhydride group, or the alkali metal borohydride-boron trihalide reagent may be produced in the presence of an organic compound containing a carboxylic acid or anhydride group. This development makes it possible to synthesize a wide variety of carbinols which are valuable and useful intermediates in organic synthesis.

专利号:WO-9734880-A1
优先权日:1996-03-18
标 题 :PROCESS FOR THE PREPARATION OF A β3-AGONIST
发明人：HO GUO J
权利人:MERCK & CO INC; HO GUO J
摘要:3-Cyclopentylpropylazide and p-chlorosulfonylphenyl-isocyanate undergo cycloaddition to form 1-cyclopropyl-4-(p-chloro-sulfonylphenyl) tetrazone-5-one, a key intermediate in the synthesis of an important β3-agonist.

专利号:US-5637757-A
优先权日:1995-04-11
标 题 :One-pot synthesis of ring-brominated benzoate compounds
发明人：HILL JOHN E; FAVSTRITSKY NICOLAI A; MAMUZIC RASTKO I; BHATTACHARYA BHABATOSH
权利人:GREAT LAKES CHEMICAL CORP
摘要:A method of preparing tetrabromobenzoate compounds from tetrabromophthalic anhydride by reacting tetrabromophthalic anhydride with alcohol in the presence of a decarboxylation catalyst. The reaction may be carried out in an excess of alcohol, or with a near stoichiometric amount of alcohol by performing the reaction in an inert solvent.

专利号:US-5705653-A
优先权日:1996-03-18
标题 :Process for the preparation of a β3 -agonist
发明人：HO GUO J
权利人:MERCK & CO INC
摘要:3-Cyclopentylpropylazide and p-chlorosulfonylphenylisocyanate undergo cycloaddition to form 1-cyclopropyl-4-(p-chlorosulfonylphenyl) tetrazone-5-one, a key intermediate in the synthesis of an important beta 3-agonist.

专利号:US-2004053999-A1
优先权日:1997-09-17
标题 :Novel compounds and methods for synthesis and therapy
发明人：BISCHOFBERGER NORBERT W; DAHL TERRENCE C; HITCHCOCK MICHAEL J M; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; MILLS ROGER G; WILLIAMS MATTHEW A
摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

专利号:US-6225341-B1
优先权日:1995-02-27
标 题:Compounds and methods for synthesis and therapy
发明人：BISCHOFBERGER NORBERT W; KIM CHOUNG U; LEW WILLARD; LIU HONGTAO; WILLIAMS MATTHEW A
权利人:GILEAD SCIENCES INC
摘要:Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.